Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ippoliti

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Leukemia|November 11, 2005
Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemiaM Bocchia, E Abruzzese, F Forconi, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 16, 2008
[Tobacco's smoke in the workplaces, webpages in the ISPESL's website]T P Baccolo, C Montaruli, A R Bianchi, et al.
ACS Catalysis|March 31, 2022
Cell-Free Total Biosynthesis of Plant Terpene Natural Products using an Orthogonal Cofactor Regeneration SystemUndramaa Bat-Erdene, John M Billingsley, William C Turner, et al.
Diseases of the Colon and Rectum|November 1, 1996
Detection of oncogene mutation from neoplastic colonic cells exfoliated in fecesC Ratto, G Flamini, L Sofo, et al.
Diseases of the Colon and Rectum|December 1, 1996
Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II studyL Sofo, C Ratto, G B Doglietto, et al.
Leukemia|August 11, 2007
CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylateM Bocchia, M Ippoliti, A Gozzetti, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2024
Total Synthesis of Lissodendoric Acid AFrancesca M Ippoliti, Laura G Wonilowicz, Nathan J Adamson, et al.
Blood|May 27, 2011
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AMLJoseph M Scandura, Gail J Roboz, Michelle Moh, et al.
Gynecologic Oncology|August 25, 2001
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancerM L Donato, D M Gershenson, J T Wharton, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Leukemia|November 11, 2005
Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemiaM Bocchia, E Abruzzese, F Forconi, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 16, 2008
[Tobacco's smoke in the workplaces, webpages in the ISPESL's website]T P Baccolo, C Montaruli, A R Bianchi, et al.
ACS Catalysis|March 31, 2022
Cell-Free Total Biosynthesis of Plant Terpene Natural Products using an Orthogonal Cofactor Regeneration SystemUndramaa Bat-Erdene, John M Billingsley, William C Turner, et al.
Diseases of the Colon and Rectum|November 1, 1996
Detection of oncogene mutation from neoplastic colonic cells exfoliated in fecesC Ratto, G Flamini, L Sofo, et al.
Diseases of the Colon and Rectum|December 1, 1996
Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II studyL Sofo, C Ratto, G B Doglietto, et al.
Leukemia|August 11, 2007
CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylateM Bocchia, M Ippoliti, A Gozzetti, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2024
Total Synthesis of Lissodendoric Acid AFrancesca M Ippoliti, Laura G Wonilowicz, Nathan J Adamson, et al.
Blood|May 27, 2011
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AMLJoseph M Scandura, Gail J Roboz, Michelle Moh, et al.
Gynecologic Oncology|August 25, 2001
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancerM L Donato, D M Gershenson, J T Wharton, et al.
Pageof 4